Trial NCT04043845

View at ClinicalTrials.gov 
Org. Study IDs: 19-277

Last trial update was posted on 2020-02-05

MeSH Interventions

Ibrutinib

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Mantle-Cell Waldenstrom Macroglobulinemia

Other Conditions

Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Marginal Zone Lymphoma

Stopping Reasons

Business development reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID